−£531
vs Dec 2024Active13502785Private limited companyHuntingdon
AMO-06 PHARMA LIMITED
Significant control: Amo Pharma Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Amo-06 Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Amo-06 Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMO-06 PHARMA LIMITED is an active private limited company (company number 13502785) incorporated on 9 July 2021, registered in Huntingdon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 December 2025, showing net assets of −£531, with 0 employees on average. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Amo Pharma Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 9 July 20215 yrs ago
- Next accounts due
- 30 September 2027in 337 days
- Confirmation statement due
- 23 July 2027in 268 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
0
vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£531 | — | — | — | — | — | 0 |
| 31 December 2024 | −£531 | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-531 at 31 December 2025
- Incorporated five or more years agoIncorporated 9 July 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 337 days
- Confirmation statement duein 268 days
- Accounts period endNet liabilities £531 · dormant accounts
- Accounts period endNet liabilities £531 · dormant accounts
- Incorporated
08
Similar companies in the UK
- AMO-01 PHARMA LIMITEDHuntingdon · inc. Jul 2021
- AWEN ONCOLOGY LIMITEDGaerwen · inc. Jul 2021
- CELLECTED LIMITEDSalisbury · inc. Jul 2021
- MICRODOT MEDICAL PRODUCTS LIMITEDHuntingdon · inc. Aug 2021
- APIDX LIMITEDNorwich · inc. Aug 2021
- TEST LABS LIMITEDPeterborough · inc. May 2021
All companies incorporated on 9 July 2021 · in Jul 2021.
09
Reminders for AMO-06 PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.